Characterization of FGF401 as a reversible covalent inhibitor of fibroblast growth factor receptor 4.
Biochemical and structural studies provide information on the mode of action of FGF401 as a selective, reversible covalent inhibitor of FGFR4. Kinase and proliferation assays reveal that FGF401 has the ability to overcome gatekeeper mutations in FGFR4.